What is the XALute Study?
The XALute Study is a clinical study (also known as a clinical trial or clinical research study) being done to learn more about an investigational immunotherapy cancer drug called Xaluritamig.
This study is for people with metastatic castration-resistant prostate cancer (mCRPC). One of the main research questions is: Will Xaluritamig help people with mCRPC live longer compared to those using existing treatment options?
Xaluritamig is being developed for advanced prostate cancer. Xaluritamig is designed to activate the immune system against prostate cancer cells. Xaluritamig has not been approved by health authorities for any use in any country. It can only be given to participants in a clinical study.
Who can participate?
These are some of the requirements to be part of the study. The study doctor will discuss the full list of requirements with you to see if you are eligible for the study.